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Abstract
We sought to determine if maternal periodontal disease is associated with oxidative stress as 
measured by serum 8-isoprostane. A secondary analysis was conducted using prospective data 
from the Oral Conditions and Pregnancy Study. Healthy women enrolled at <26 weeks’ 
gestational age underwent oral examination and serum sampling. Maternal periodontal disease 
status was categorized as healthy, mild, or moderate to severe by clinical criteria. Maternal serum 
was analyzed for 8-isoprostane using ultrasensitive enzyme-linked immunosorbent assay. Elevated 
8-isoprostane level was defined as ≥75th percentile. Maternal factors associated with elevated 8-
isoprostane were determined using chi-square or t test. Multivariable logistic regression was used 
to assess association between elevated 8-isoprostane and maternal factors. Seven hundred ninety-
one women had complete data. Median (interquartile) 8-isoprostane serum level was 1806 (16 to 
81,870) pg/dL. Using bivariate analysis, maternal age, race, marital status, utilization of public 
assistance, and mild or moderate to severe periodontal disease were associated with elevated 
serum 8-isoprostane. Using logistic regression, moderate to severe periodontal disease (adjusted 
odds ratio 2.9, 95% confidence interval: 1.7 to 5.0) remained significantly associated with an 
elevated serum 8-isoprostane level. Maternal periodontal disease is associated with oxidative 
stress during pregnancy. Further study is needed to determine the role of maternal oxidative stress 
in periodontal disease-associated adverse pregnancy outcomes.
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Oxidative stress is characterized by a state of imbalance between free radicals and 
antioxidant defenses. Free radicals are produced endogenously as part of the oxidative burst 
of phagocyte activation, and they are encountered via exogenous production from sources 
such as cigarette smoke. When an excess production of reactive oxygen species is formed, 
oxidative stress ensues. A member of the isoprostane family, 8-isoprostane PGF2α (8-iso), 
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has been advocated as the “gold standard” for measurement of in vivo “whole-body” 
oxidative stress.1,2 The 8-iso is predominantly generated by cyclo-oxygenase-independent 
free radical attack on arachidonic acid in cell membranes.
Oxidative stress plays an important role in the pathogenesis of periodontal disease and its 
complications.3,4 Individuals with periodontal disease display high levels of local and 
systemic biomarkers of oxidative stress.5 This has potential relevance for the pregnant 
woman, as periodontal disease affects 5 to 40% of pregnant women. Additionally, 
periodontal disease has been associated with preeclampsia and adverse pregnancy outcomes 
characterized by impaired antioxidant defense and maternal oxidative stress.6–8 Women 
destined to develop preeclampsia have increased systemic concentrations of 8-iso early in 
pregnancy, prior to the clinical manifestation of the disease.9 Recently, Wikström and 
colleagues demonstrated an association between elevated placental 8-iso and early onset 
preeclampsia.10 Maternal periodontal disease may be a stimulus for this increase in 
oxidative stress.
The objective of this analysis was to determine if maternal periodontal disease was 
associated with oxidative stress during pregnancy, which may suggest a possible therapeutic 
target to reduce periodontal disease-associated pregnancy complications.
METHODS
This is a secondary analysis of data from the Oral Conditions and Pregnancy study, which 
was a prospective cohort performed at the Center for Oral and Systemic Disease, School of 
Dentistry, University of North Carolina, Chapel Hill, North Carolina, in collaboration with 
Duke University Medical Center, Durham, North Carolina, from December 1997 through 
July 2001. The primary goal was to evaluate obstetric outcome in women with various 
stages of periodontal health and disease. Study design and procedures have been fully 
described previously.11 The Duke University Medical Center and the University of North 
Carolina Institutional Review Boards granted approval to conduct this study, and written 
informed consent was obtained from all study participants.
Over a 42-month period, healthy women with a singleton pregnancy were enrolled at <26 
weeks of gestation, with 40% of the women enrolled at less than 14 weeks’ gestation. 
Demographic information, health behaviors, and medical history data were obtained by 
subject questionnaire and direct interview at the first visit, which were reviewed by a 
physician at the first prenatal visit. Race was determined by maternal self-report. Women 
were considered to have used alcohol or tobacco if, by their report, they had used any since 
their last missed menstrual period. All women underwent periodontal examinations and 
maternal serum specimen collection at enrollment. Periodontal disease status was defined as 
“healthy,” “mild,” or “moderate to severe” based on clinical criteria.6 For the purpose of this 
analysis, periodontal health was defined as the absence of gingival pocket depths greater 
than or equal to 4 mm and no pockets greater than 3 mm that bled on probing. Mild 
periodontal disease was defined as one or more tooth sites with greater than or equal to 4-
mm pocket depth or one or more pockets that bled on probing, up to 15 tooth sites. Moderate 
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to severe periodontal disease was considered present if 15 or more tooth sites had pocket 
depth greater than or equal to 4 mm.11
Blood was drawn from all women at the time of enrollment via standard venipuncture 
technique. Samples were then centrifuged and frozen at −80°C. For this analysis, total serum 
8-iso quantification was performed using a commercially available ultrasensitive enzyme-
linked immunoassay (Assay Designs’ Direct 8-iso-PGF2α kit, Biomol, Hamburg, Germany) 
at a single laboratory at the Center for Oral and Systemic Disease, School of Dentistry, 
University of North Carolina, Chapel Hill, North Carolina. The lower limit of detection of 
this assay is of 0.022 pg/mL, with inter-and intra-assay variability of 5.4% and 10.4%, 
respectively. There are no currently accepted standard normal values for 8-iso, and the 
literature does not suggest a threshold value above which clinically relevant findings are 
seen. Therefore, for this analysis, we defined elevated as serum quartile levels of 8-iso 
greater than or equal to the 75th percentile, which corresponded to a level >81,870 pg/mL in 
our cohort. Bivariate analysis was performed to determine association between elevated 8-
iso and maternal factors using chi-square or t test. Maternal factors that were associated with 
an elevated 8-iso level at p <0.1 were entered into a multivariable logistic regression model 
to determine the adjusted odds ratios and 95% confidence intervals (CIs) for an elevated 8-
iso level. A more parsimonious model was then determined by backward, stepwise logistic 
regression. Statistical analyses were performed using Statistical Analysis Software, version 
9.1 (SAS, Cary, NC).
RESULTS
A total of 791 women had complete data and serum samples available for analysis. The 
median gestational age at enrollment was 14 weeks with a range of 4 to 26 weeks. 
Demographic, medical, and obstetric data of the women who made up the cohort for this 
analysis are shown in Table 1. Maternal age, race, marital status, low socioeconomic status 
as indicated by eligibility for the Women and Infant Care program and/or food stamps, and 
presence of moderate to severe periodontal disease, were associated with elevated serum 8-
iso level.
Multivariable regression models for an elevated serum 8-iso level are shown in Tables 2 and 
3. After accounting for potential confounders such as socioeconomic status, maternal 
moderate to severe periodontal disease in early pregnancy remained significantly associated 
with an elevated serum 8-iso level (Table 3).
DISCUSSION
We found that low socioeconomic status and the presence of moderate to severe periodontal 
disease are significantly associated with increased oxidative stress as measured by maternal 
serum 8-iso. Pregnancy is inherently a state of oxidative stress due to the increased 
metabolic activity in placental mitochondria and the reduced scavenging power of 
antioxidants. The isoprostanes are a specific marker for oxidative damage to lipids from 
endogenous lipid peroxidation. They are prostaglandin-like compounds derived by auto-
oxidation of the arachidonic acid moiety.12 The F2 isoprostanes, including 8-iso, are 
Hickman et al. Page 3













chemically stable, specific products of peroxidation. They are formed in vivo and are present 
in detectable amounts in all normal tissues and biological fluids. In addition to serving as a 
marker of oxidative damage, they possess biological activity of their own via 
vasoconstrictive effects in the lung and kidney. The F2 isoprostanes do not exhibit normal 
diurnal variation, and they are known to substantially increase in animal models of oxidant 
injury, without influence of the lipid content of the diet.13 In vitro measurement of the F2 
isoprostanes is considered the best available marker of in vivo oxidative stress.
Periodontal disease is a significant oral health condition commonly encountered in pregnant 
women.11 The association between periodontal disease and adverse pregnancy outcome has 
been the subject of several studies with inconsistent conclusions. Some have demonstrated 
an association between periodontal disease and adverse pregnancy outcomes such as preterm 
birth, preeclampsia, and low birth weight in various populations,14–17 although others have 
not confirmed this association.18 Perhaps this disparity is due to differences in the 
definitions used for assessing the presence of periodontal disease.19 However, in our cohort 
of women, maternal periodontal disease has been associated with elevated maternal 
inflammation,20 which may contribute to the risk for preeclampsia.21 Others have also noted 
an association between elevated levels of oxidative stress in women with preeclampsia 
compared with gestation-matched control women.10 Data suggest that the increased 8-iso 
could be due to increased oxidative stress in preeclampsia or a decrease in renal clearance 
with the vasoconstrictive activity of 8-iso a potential contributor to the pathogenesis of 
preeclampsia.22 Our data demonstrate that moderate to severe periodontal disease is 
associated with maternal oxidative stress as measured by serum 8-iso, supporting the 
findings of others that the effects of periodontal disease do not remain localized.
Prior studies examining the impact of localized treatment of periodontal disease during 
pregnancy to decrease adverse outcome have had mixed results. In their large intervention 
trial, Offenbacher et al found a significant reduction in preterm birth among women who 
received treatment of their periodontal disease during pregnancy.23 However, most recently, 
Macones et al reported the results of their randomized clinical trial of periodontal disease to 
reduce preterm birth. Notably, the overall occurrence of preterm birth was not decreased in 
the women who received treatment; however, among women who received treatment, a 
greater proportion experienced a medically indicated preterm delivery (3.3% versus 1.1%; 
relative risk 3.01; 95% CI, 0.95 to 4.24).24 The next step is to determine if maternal 
oxidative stress in response to periodontal disease may be part of the pathophysiology of 
periodontal-associated adverse pregnancy outcomes and whether the inclusion of antioxidant 
therapy with periodontal disease treatment might improve obstetric outcome in affected 
women.
Several limitations of our study merit discussion. Our study population included a 
significant number of African-American women who are known to have worse periodontal 
disease than their Caucasian counterparts and have higher concentrations of systemic 
inflammation.20,25 Racial, educational, and socioeconomic status disparities have been 
previously associated with periodontal disease. African-Americans, especially those of 
lower socioeconomic status, are less likely to seek preventive dental services, and they have 
higher rates of periodontal disease compared with non-Hispanic white populations and 
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African-Americans of higher socioeconomic status.25 Internationally, the reports of 
increased periodontal disease among members of lower socioeconomic groups are noted 
even in the setting of universal, government-sponsored dental care, which points to the 
significant effects education and attitude toward dental health may have.26,27
In conclusion, moderate to severe periodontal disease is associated with oxidative stress in 
early pregnancy, as measured by serum 8-iso. Future research is needed to gather 
longitudinal data on biomarkers of oxidative stress, to determine if the treatment of maternal 
periodontal disease alters maternal oxidative stress during pregnancy and whether 
antioxidant therapy should be considered as part of the treatment of periodontal disease 
during pregnancy.
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Table 1
Characteristics of the Study Cohort
Maternal Characteristics
Whole Cohort (n 
=791)
Serum 8-Isoprostane 
<75th Percentile (n =593)
Serum 8-Isoprostane 
≥75th Percentile (n =198) p Value
Age, y (mean ±SD) 28 ±6.5 29 ±6.5 27.0 ±6.6 0.0007
Weight at enrollment (pounds, mean ±SD) 162 ±44.7 162 ±42.5 167 ±51.2 0.08
Race <0.0001
 Caucasian 367 (46) 311 (52) 68 (34)
 African-American 379 (48) 251 (42) 116 (59)
 Other 45 (6) 31 (5) 14 (7)
Married 402 (51) 324 (55) 78 (39) 0.0002
Unmarried 389 (49) 269 (69) 120 (61)
WIC/food stamps 174 (22) 104 (60) 70 (40) <0.0001
First pregnancy 313 (40) 236 (40) 77 (39) NS
Tobacco use 135 (17) 93 (16) 44 (22) 0.07
Alcohol use 123 (16) 88 (15) 35 (18) NS
Periodontal disease status <0.0001
 Healthy 218 (28) 182 (31) 36 (18)
 Mild 459 (58) 347 (59) 112 (57)
 Moderate–severe 114 (41) 64 (11) 50 (25)
Data presented as n (%) unless otherwise noted. SD, standard deviation; WIC, Women and Infant Care program.
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Table 2
Full Multivariable Regression Model for an Elevated Serum 8-Isoprostane Level
Maternal Characteristic Adjusted Odds Ratio* (95% Confidence Interval)
Age 0.98 (0.95–1.01)
Weight 1.0 (1.00–1.01)
African-American race 1.18 (0.78–1.79)
Married 0.94 (0.61–1.45)
WIC/food stamp eligible 1.74 (1.16–2.61)
Smoked during pregnancy 1.10 (0.71–1.71)
Mild periodontal disease 1.38 (0.82–2.00)
Moderate/severe periodontal disease 2.59 (1.45–4.60)
*
Adjusted for all variables listed.
WIC, Women and Infant Care program
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Table 3
Reduced Multivariable Regression Model for an Elevated Serum 8-Isoprostane Level
Maternal Characteristic Adjusted Odds Ratio* (95% CI)
Age 0.97 (0.95–0.99)
WIC/food stamp eligible 1.87 (1.26–2.77)
Mild periodontal disease 1.37 (0.89–2.12)
Moderate–severe periodontal disease 2.89 (1.67–5.00)
*
Adjusted for all variables listed.
CI, confidence interval; WIC, Women and Infant Care program.
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